» Articles » PMID: 31012234

Association Between Glaucoma and the Risk of Alzheimer's Disease: A Systematic Review of Observational Studies

Overview
Journal Acta Ophthalmol
Specialty Ophthalmology
Date 2019 Apr 24
PMID 31012234
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To address inconsistency as well as investigate the relationship between glaucoma and the risk of Alzheimer's disease (AD). We systematically conducted this meta-analysis based on observational studies published up to 15 January 2018, identified from PubMed and Web of Science. Two team members independently extracted the data and assessed the quality of each included study. Summary relative risk (RR) and 95% confidence intervals (CIs) were calculated using a random-effects model. Eight observational studies with 6870 AD cases were included. The majority of these studies (n = 6) were graded as low risk according to the Newcastle-Ottawa Quality Assessment Scale. Individuals diagnosed with glaucoma, compared to those who were not, had an increased risk of AD (RR = 1.52; 95% CI: 1.41-1.63; I  = 97%, p < 0.001). A significant finding was also observed for primary open-angle glaucoma (RR = 1.52; 95% CI: 1.41-1.63; I  = 97%, p < 0.001). However, when stratified by study design, only the case-control studies (RR = 1.08; 95% CI: 0.89-1.31; I  = 37.3%, p = 0.207) yielded significant results, while the cohort studies did not (RR = 1.08; 95% CI: 0.89-1.31; I  = 97.7%, p < 0.001). Of note, our meta-regression analysis suggested that study design might be a source of heterogeneity (p = 0.009). Additionally, a significantly positive association was observed when the analyses were restricted to Asia (RR = 2.03; 95% CI: 1.02-4.07). There was no significant publication bias in these analyses. Recent evidence suggests that glaucoma may increase the risk of AD. Additional cohort studies are needed to confirm these findings and to have improved knowledge on the true nature of this association.

Citing Articles

Association of hearing, vision, and dual sensory impairment and risk of Alzheimer's disease: a nested case-control study.

Rajamaki B, Hokkinen K, Dietz A, Kaarniranta K, Hartikainen S, Tolppanen A BMC Geriatr. 2024; 24(1):929.

PMID: 39528963 PMC: 11552362. DOI: 10.1186/s12877-024-05514-z.


Longitudinal Assessment of Retinal Microvasculature in Preclinical Alzheimer's Disease.

Curro K, van Nispen R, den Braber A, Van De Giessen E, van de Kreeke J, Tan H Invest Ophthalmol Vis Sci. 2024; 65(12):2.

PMID: 39361291 PMC: 11451830. DOI: 10.1167/iovs.65.12.2.


The association between antiglaucomatous agents and Alzheimer's disease.

Chou C, Lu Y, Weng C, Lin H, Wang I, Jou T Eye (Lond). 2024; 38(18):3511-3518.

PMID: 39341977 PMC: 11621119. DOI: 10.1038/s41433-024-03348-y.


Exploring Cognitive Impairments Associated with Primary Open-Angle Glaucoma and Exfoliation Glaucoma.

Kadoh Y, Kubota S, Shimomine S, Tanito M Biomedicines. 2024; 12(8).

PMID: 39200171 PMC: 11351631. DOI: 10.3390/biomedicines12081706.


Primary Open-Angle Glaucoma Is Associated with Short-Term Memory Decline and Dementia in Individuals of African Ancestry.

Sapir T, Augello P, Lee R, McCoskey M, Salowe R, Addis V J Clin Med. 2024; 13(14.

PMID: 39064180 PMC: 11278361. DOI: 10.3390/jcm13144140.